Catalyst Wire Dossier Catalyst Wire Dossier

Bivalent meningococcal serogroups A and C tetanus toxoid conjugate vaccine

· Jiangsu Province Centers for Disease Control and Prevention
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bivalent meningococcal serogroups A and C tetanus toxoid conjugate vaccine, covering 2018-10-22 to 2018-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese [Phase 3]

See pricing